Symbiosis Pharmaceutical Services is Pharmaceuticals in United Kingdom that focus on low volume business. Founded in 2011. They cover business area such as Provider, contract manufacturing service, sterile drug product, sterile fill-finish, vial, clinical trial, low volume commercial supply, biotech and pharmaceutical company, increase market demand, regulatory compliance.
2011
( 13 years old in 2024 )
Low Volume
-
Scion House
Stirling Innovation Park
Stirling FK9 4NF
Scotland, United Kingdom
Private
Providercontract manufacturing servicesterile drug productsterile fill-finishvialclinical triallow volume commercial supplybiotech and pharmaceutical companyincrease market demandregulatory compliance
* We use standard office opening hours in near Symbiosis Pharmaceutical Services's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Symbiosis Pharmaceutical Services is Pharmaceuticals business from United Kingdom that founded in 2011 (13 years old in 2024), Symbiosis Pharmaceutical Services business is focusing on Low Volume.
Symbiosis Pharmaceutical Services headquarter office and corporate office address is located in Scion House Stirling Innovation Park Stirling FK9 4NF Scotland, United Kingdom.
Symbiosis Pharmaceutical Services was founded in United Kingdom.
In 2024, Symbiosis Pharmaceutical Services is currently focus on low volume sector.
Above is snippet of Google Trends for "low volume" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Symbiosis Pharmaceutical Services, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.